Send us a text

Safety in the workplace hinges on supervisors' ability to recognize potential impairment – but how exactly should they make these critical determinations? Joe Reilly and Tom Fulmer, incoming president of the Substance Abuse Program Administrators Association, tackle this question head-on with practical insights for employers navigating the complexities of reasonable suspicion testing.

The conversation reveals a crucial distinction many employers miss: the difference between immediate and non-immediate reasonable suspicion. While immediate situations require swift action based on specific, observable behaviors that suggest current impairment, non-immediate scenarios involve patterns of concerning behavior over time. Each requires a different approach, documentation method, and confrontation technique.

"Don't try and diagnose the problem. You're not a clinician," Reilly emphasizes, highlighting that reasonable suspicion isn't about catching employees or making accusations – it's fundamentally about workplace safety. The experts share valuable guidance on proper documentation (using objective criteria rather than subjective judgments), confrontation methods that keep discussions on track, and the importance of confidentiality throughout the process.

Perhaps most valuable is their practical advice for supervisors, including never allowing potentially impaired employees to drive, keeping emotions in check during confrontations, and understanding that many behaviors that mimic impairment could have alternative explanations like medical conditions or personal crises. The discussion underscores why supervisor training isn't just a compliance checkbox but an essential safety tool that can prevent accidents, reduce liability, and potentially save lives.

Whether you're developing a drug-free workplace program, training supervisors, or looking to strengthen your reasonable suspicion protocols, this episode delivers actionable insights that balance workplace safety with employee dignity. Subscribe to our channel and ring the bell to receive notifications when we upload new content about workplace drug testing and safety policies.

Send us a text

Navigating the complex world of workplace drug testing starts with understanding what you're actually testing for. In this illuminating conversation with Tom Fulmer, Vice President of Business Development at National Drug Screening, we unpack the sometimes confusing terminology around drug testing "panels" and what employers need to know to make informed decisions.

Did you know that a standard "5-panel" drug test can actually detect up to 13 different substances? We explore what makes up the foundation of workplace drug testing programs, from the DOT-mandated SAMHSA 5-panel to expanded options that include emerging drugs of concern like fentanyl. Tom shares his journey from having no drug testing experience to becoming the incoming president of the Substance Abuse Program Administrators Association, offering a unique perspective on how the industry has evolved.

For employers struggling with marijuana testing policies amid changing state laws, we offer practical guidance on developing compliant approaches. Whether you're operating in a single state or managing a multi-state workforce with different legal requirements, you'll learn strategies for crafting effective policies that balance safety concerns with legal compliance. We break down the differences between testing methods (lab-based vs. instant, urine vs. oral fluid vs. hair) and how panel options vary across these platforms.

Looking toward the future, we discuss SAMHSA's recent addition of fentanyl testing for federal employees, what this might mean for DOT regulations, and trends toward more customizable testing panels. Whether you're new to workplace drug testing or looking to update your current program, this episode provides the knowledge you need to select the right panels for your organization's needs. Have questions about your specific situation? Reach out to us directly at joe@nationaldrugscreening.com.

Send us a text

What does it really take to start a successful drug testing business? Forget the TikTok get-rich-quick schemes promising overnight success - this episode delivers the unvarnished truth from someone who's actually done it.

Brandy Helveston, owner of Straight Line Mobile Testing and Lab Services LLC, shares her remarkable journey from initial concept to launching her thriving mobile drug testing business. After nearly five years of meticulous research and preparation, Brandy reveals the strategic decisions, challenges, and practical steps that transformed her vision into reality.

The conversation tackles crucial considerations often overlooked by newcomers: choosing between mobile operations versus brick-and-mortar facilities, identifying trustworthy mentorship, establishing essential business infrastructure, and most importantly - developing effective marketing strategies. As Brandy emphasizes repeatedly, success requires being "boots on the ground every single day" actively pursuing clients rather than expecting labs to deliver business to your doorstep.

For aspiring entrepreneurs, this episode serves as both inspiration and warning. While Brandy demonstrates that launching a drug testing business is indeed achievable with proper preparation, she also dispels dangerous misconceptions propagated by dubious online "experts" promising instant success after brief training courses. Her candid insights about categorizing marketing targets, leveraging community resources like chambers of commerce, and building a supportive team provide a practical roadmap for those serious about entering the industry.

Whether you're considering starting a drug testing business or simply interested in entrepreneurship, this conversation offers valuable lessons about research, patience, and persistence that apply across all business ventures. Ready to learn what it really takes to succeed in this specialized field? This episode delivers the unfiltered reality you need to hear.